OCUSERT PILO-20 (pilocarpine) by Epic Pharma Llc is clinical pharmacology pharmacodynamics pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. First approved in 1974.
Drug data last refreshed 13h ago · AI intelligence enriched 2d ago
OCUSERT PILO-20 is an extended-release ophthalmic insert containing pilocarpine 20 mcg, a cholinergic parasympathomimetic agent that stimulates muscarinic receptors. It treats glaucoma and ocular hypertension by causing miosis and reducing intraocular pressure through enhanced aqueous humor outflow. The drug has been marketed since 1974 and represents a sustained-release formulation approach to chronic eye pressure management.
Product approaching loss of exclusivity with minimal linked job activity, signaling reduced commercial team investment and potential headcount consolidation.
CLINICAL PHARMACOLOGY Pharmacodynamics Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. Pilocarpine, in appropriate dosage, can increase secretion by the exocrine glands. The sweat, salivary, lacrimal,…
Worked on OCUSERT PILO-20 at Epic Pharma Llc? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Working on OCUSERT PILO-20 offers limited career growth opportunity given the product's LOE-approaching status and minimal linked job openings. Positions on this product are typically maintenance-focused, suited for specialists managing mature product portfolios rather than those seeking dynamic launch or expansion roles.